Health-care companies fell as traders digested a mixed round of earnings for the sector. Hims & Hers is under political pressure amid controversy about the telehealth firm's Super Bowl ad touting an ...
Bain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
Bain Capital entered a deal to acquire Mitsubishi Tanabe Pharma Corporation (MTPC) from Mitsubishi Chemical Group for 510 ...
The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...
The Mitsubishi Chemical Group is selling its centuries-old pharmaceutical business to Bain Capital in a carve-out worth about ...
Bausch + Lomb's efforts to sell have so far been unsuccessful. Meanwhile, KKR is aggressively pursuing a deal for Fuji Soft.
Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...
Mitsubishi Corp has recorded an impairment charge of Y52.2bn ($342.4m) on its offshore wind projects in Japan.
In January, Standout Capital agreed to become a majority shareholder in Tjekvik. Headquartered in Copenhagen, Tjekvik is a provider of self-service software services for the automotive after-sales ...
Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...
The report suggests that USAID could have seen its 10,000-strong workforce reduced to just 300, with the new figure emerging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results